[T1结直肠癌的治疗]
Nina C A Vermeer1,2, Leon M G Moons3, Jurjen J Boonstra4
1Antoni van Leeuwenhoek, afd. Heelkunde, Amsterdam.
Nederlands tijdschrift voor geneeskunde
|August 1, 2024
概括
对于疑似T1结直肠瘤,建议进行完整的内镜切除. 高风险特征需要考虑用淋巴管切除术进行手术切除,因为仅使用内镜方法后存在未知的复发风险.
科学领域:
- 胃肠道学和外科瘤学
- 结肠直肠癌研究研究
背景情况:
- T1结肠直肠瘤需要进行完整的阻断切除,而不是活检.
- 内镜技术的进步使得T1瘤的彻底切除更频繁.
研究的目的:
- 根据特定的病理特征来定义高风险T1结直肠瘤.
- 评估对高风险T1结直肠瘤进行淋巴切除术的手术切除的必要性.
- 为了解决高风险T1结直肠瘤内镜切除后疾病复发的未知风险.
主要方法:
- 基于差差分化,血管侵入,高度瘤芽 (2-3级) 和正切除边缘 (≤0.1mm) 的高风险T1结直肠瘤的鉴定.
- 对管理T1结直肠瘤的当前建议的审查.
- 对内镜切除与手术切除对早期肠癌的影响的讨论.
主要成果:
- 高风险的T1结直肠瘤具有特定的不良病理特征.
- 建议在高风险的T1结直肠瘤中进行淋巴切除术.
- 没有手术的高风险T1瘤内镜切除后复发的风险仍然不清楚.
结论:
- 对于疑似T1结直肠瘤,完全内镜切除是标准的.
- 高风险的T1结直肠瘤需要考虑手术切除和淋巴切除术.
- 早期的肠癌手术带来了与更先进的阶段相比的风险.
更多相关视频
04:22Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
405
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
1.8K
相关概念视频
01:21Inflammatory Bowel Disease V: Surgical Management
138
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
138
01:29Drugs for Treatment of Ulcerative Colitis in IBD
133
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
133
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
110
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
110
01:17Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156